YF

Yantai Financial Investment Holding

Description

Yantai Financial Investment Holding

Investor Profile

Yantai Financial Investment Holding has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in China, United States.
  • Strong thematic focus on Biotechnology, Consumer Goods, Product Research.

Stage Focus

  • Series B (100%)

Country Focus

  • China (50%)
  • United States (50%)

Industry Focus

  • Biotechnology
  • Consumer Goods
  • Product Research
  • Association
  • Manufacturing
  • Non Profit
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Yantai Financial Investment Holding frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Qiandao Fund
Asia, Beijing, China, Beijing
Co-Investments: 2
Ligong investment
Asia, Shanghai, China, Putuo
Co-Investments: 2
Sunshine Insurance Group
Asia, Beijing, China, Beijing
Co-Investments: 2
DT Capital Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 2
China Merchants Securities
Asia, Guangdong, China, Shenzhen
Co-Investments: 2
Huajin Capital
Asia, Guangdong, China, Zhuhai
Co-Investments: 2
XT
Asia, Zhejiang, China, Ningbo
Co-Investments: 2
YI
Asia, Fujian, China, Qingdao
Co-Investments: 1
Horus Capital
Asia, Shandong, China, Qingdao Shi
Co-Investments: 2

What are some of recent deals done by Yantai Financial Investment Holding?

Norson Biotechnology

Pingdu, Shandong, China

Norson Biotechnology produces edible probiotic powders, fermented lactic acid bacteria beverages, and other products.

BiotechnologyConsumer GoodsProduct Research
Series BJun 8, 2020
Amount Raised: $70,708,356
MabPlex International

Fremont, California, United States

MabPlex provides CDMO services in the development and manufacturing of biopharmaceuticals.

AssociationBiotechnologyManufacturingNon Profit
Series BJun 8, 2020
Amount Raised: $70,708,356